The Food and Drug Administration is asking for 75 years – twenty years more than it originally agreed – in order to comply with demands for basic transparency and accountability over its December 2020 decision to grant Pfizer-BioNTech "Emergency Use Authorization" for its mRNA therapeutic drugs bein...
